Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Letters to the Editor

John P. Lavery, MD  |  Issue: March 2011  |  March 18, 2011

Dear Dr. Panush:

I appreciated what you wrote about FMGs in the latest edition of The Rheumatologist [January 2011, p. 21]. As an American FMG myself, I always found it interesting how the medical establishment was always dismissive of medical care and physicians outside of the United States. Any studies or achievements developed outside of the United States were often disposed as inferior by my attendings. My qualities as a physician were also belittled as a result of my foreign medical degree. This later dried up as I became chief resident, finished two subspecialty fellowships, and achieved board certification in three specialties.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

You rightly point out the reality of FMGs in the United States, especially in New Jersey, but I have come to realize our patients are also from other countries.

But you are right, things have changed. The rest of the world has caught up with us and has passed us. Fareed Zarekia wrote a book about it, The Rise of the Rest. Globalization and the Internet are a reality. Rheumatology is no exception. EULAR is now seen as a premier meeting. The adoption and the sophisticated utilization of technologies such as video nailfold capillaroscopy and diagnostic ultrasound in Europe are light years ahead of the progress of the United States. We are now competing in a global environment.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

You rightly point out the reality of FMGs in the United States, especially in New Jersey, but I have come to realize our patients are also from other countries. They do not always share the prejudices against FMGs that the American establishment harbored. They will seek out physicians from their own countries. Although I am American, I have Mexican patients seeking me out specifically because of my foreign degree in Mexico. They want someone who speaks their language and knows their culture. I have seen Mexican doctors posting their Mexican degree and their American postgraduate studies as a marketing tool in Spanish language advertising.

I remember your commentaries in the Yearbooks of Rheumatology and always admired your intellectual honesty. “Rheum with a View” is not different. Please keep up the good work.

John P. Lavery, MD
Allergy/Rheumatology
Allen, Texas

Share: 

Filed under:Practice Support Tagged with:Internationalpatient carerheumatologist

Related Articles

    Rheum With a View

    January 17, 2011

    Panush’s perspectives on selections from the literature

    Clinical Trials Go Global

    November 1, 2011

    As medical research expands to the global population, will trial results sill apply to U.S. populations?

    Make Rehab Fun: Virtual Reality & Therapeutic Gaming

    December 12, 2019

    Using virtual reality in rehabilitation can have benefits—as long as it is properly understood. In fact, some evidence suggests benefits from the judicious use of immersive virtual reality with patients with rheumatic diagnoses. People tend to have a lower perception of effort compared with actual exertion and lower reports of pain with longer time to exhaustion.

    Letters to the Editor

    June 1, 2007

    Feedback from Our Readers

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences